Target intelligence / Profile preview

Coagulation factor XIII B chain (F13B)

Target
F13B
Molecular classification
Enzyme (as part of a zymogen complex), Carrier/regulatory subunit (non-catalytic), Other (Coagulation factor)
01

Overview

Coagulation factor XIII B chain is a plasma protein encoded by the F13B gene that forms part of the factor XIII heterotetramer (A2B2), essential for the final steps of the blood clotting cascade.[1][2][3][4][5] The B chain acts as a regulatory and carrier subunit: it stabilizes the catalytic A subunits in circulation until activation by thrombin and calcium ions, at which point the B subunits dissociate, enabling the A subunits to cross-link fibrin and stabilize blood clots.[1][2][3][5] Deficiency of the B chain results in a rare bleeding disorder with impaired wound healing, and F13B is also implicated in other physiological functions such as angiogenesis, bone formation, and immune response.[1][2][3][5] While therapeutic targeting is not typical except for replacement in deficiency, it is a crucial molecule for hemostasis.[1][3][5]

Other names
FXIIIBFibrin-stabilizing factor B subunitProtein-glutamine gamma-glutamyltransferase B chainTransglutaminase B chainTGaseCoagulation factor XIII, B polypeptide
02

Mechanism of action

Replacement therapy to restore clot stability and coagulation in deficiency

03

Biological functions

Blood coagulationClot stabilizationFibrinolysis regulationCarrier function (for A subunit, stabilization in plasma)Wound healingAngiogenesisImmune responseBone formation
04

Disease associations

Cardiovascular diseaseBleeding disorders (including congenital factor XIII deficiency)Pregnancy-related complications (habitual abortion)Age-related macular degeneration
05

Safety considerations

Thrombosis risk (with excessive replacement)Anaphylactic reactions (to plasma products)Allergic or immune reaction to exogenous factor XIII
06

Interacting drugs

Recombinant factor XIII (for deficiency)

1 more in the full profile.

07

Biomarkers

Factor XIII activity (to diagnose deficiency)F13B gene mutation testing (for inherited bleeding disorder)

Beyond the preview

Go deeper on Coagulation factor XIII B chain (F13B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation factor XIII B chain (F13B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call